Next Article in Journal
The Differential Roles for Neurodevelopmental and Neuroendocrine Genes in Shaping GnRH Neuron Physiology and Deficiency
Previous Article in Journal
The Interaction of Heptakis (2,6-di-O-Methyl)-β-cyclodextrin with Mianserin Hydrochloride and Its Influence on the Drug Toxicity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 22
Issue 17
10.3390/ijms22179421
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Usage of Natural Volatile Organic Compounds as Biological Modulators of Disease

by
Min-Hee Kim
1,†,
Seung-Min Lee
2,†,
Ki-Wan An
3,
Min-Jae Lee
2,* and
Dae-Hun Park
1,*
1
College of Korean Medicine, Dongshin University, Naju 58245, Korea
2
School of Veterinary Medicine, Kangwon National University, Chuncheon 24341, Korea
3
Department of Forest Resources, Chonnam National University, Gwangju 61186, Korea
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2021, 22(17), 9421; https://doi.org/10.3390/ijms22179421
Submission received: 30 July 2021 / Revised: 22 August 2021 / Accepted: 23 August 2021 / Published: 30 August 2021
(This article belongs to the Section Biochemistry)
Browse Figures
Versions Notes

Abstract

:
Plants produce a wide variety of natural volatile organic compounds (NVOCs), many of which are unique to each species. These compounds serve many purposes, such as fending off herbivores and adapting to changes in temperature and water supply. Interestingly, although NVOCs are synthesized to deter herbivores, many of these compounds have been found to possess several therapeutic qualities, such as promoting nerve stability, enhancing sleep, and suppressing hyperresponsiveness, in addition to acting as antioxidants and anti-inflammatory agents. Therefore, many NVOCs are promising drug candidates for disease treatment and prevention. Given their volatile nature, these compounds can be administered to patients through inhalation, which is often more comfortable and convenient than other administration routes. However, the development of NVOC-based drug candidates requires a careful evaluation of the molecular mechanisms that drive their therapeutic properties to avoid potential adverse effects. Furthermore, even compounds that appear generally safe might have toxic effects depending on their dose, and therefore their toxicological assessment is also critical. In order to enhance the usage of NVOCs this short review focuses not only on the biological activities and therapeutic mode of action of representative NVOCs but also their toxic effects.

1. Introduction

Natural volatile organic compounds (NVOCs), also known as biogenic volatile organic compounds, are compounds that derive from living organisms such as plants. Further, volatile organic compounds (VOCs) are organic compounds that are volatile at environmental temperature; however, this definition may vary between countries and jurisdictions. For example, Canada defines VOCs as organic compounds with boiling points between 50 and 250 °C [1], whereas the European Union defines them as organic compounds with an initial boiling point less than or equal to 250 °C measured at a standard atmospheric pressure of 101.3 kPa [2]. In India [3] and the United States of America [4], these compounds tend to be defined from an environmental pollutant standpoint.
NVOCs are primarily synthesized by plants to deter herbivores [5,6] and to promote plant growth [7]. Given that the types of NVOCs produced by plants are largely species-dependent [8], plants are often phenotyped based on their unique NVOC characteristics and ratios [9]. NVOCs can be classified based on their origin (e.g., synthetic vs. natural) chemical structure (e.g., isoprenoids or terpenoids), or chemical moieties (e.g., oxygenated forms such as methanol, acetaldehyde, acetone, methyl-ethyl-ketone, or sulfurs such as furanocoumarins) [10,11]. The diversity and level of the emitted NVOCs are also determined by a variety of stimuli such as temperature and light [12,13,14], water and humidity [15,16], salt concentration [17], or the presence of ozone [18,19], among other factors.
Recent reports have discussed the many therapeutic qualities of NVOCs, including their ability to enhance sleep [20]; hypolipidemic activity and anti-cancer effect [21,22]; protective effect against viral pneumonia and anti-inflammatory effects [23]; anti-cancer and anti-oxidative effects [24,25]; neuroprotective effects [26]; anti-oxidative stress and anti-asthmatic effects [27,28,29]; alleviating effect on skin inflammation [30]; anti-Trypanosoma effects [31]; and industrial applications such as flavoring agents for food additives, oil for aromatherapy, commercial chemicals for many food products, soaps, and perfume [32]. However, NVOCs can also exert toxic effects, such as irritation of the pulmonary system and central nervous system [33], developmental toxicity [34,35], nephrotoxicity and hepatotoxicity [36], and allergic reactions [37,38]. Therefore, this review discusses the biological and toxicological effects of NVOCs that could be used as biological modulators of disease.

2. Biological Effects of Natural Volatile Compounds

2.1. (+)-3-Carene

(+)-3-carene is a monoterpene that is often also referred to as isodiprene, (+)-δ3-carene, δ-3-carene, and (+)-car-3-ene [39]. This compound has several biological effects such as antibacterial [40], insecticidal [41], and sleep-enhancing [20] properties. Further, Shu et al. (2019) reported that this compound induced the death of Gram-positive Brochothrix thermosphacta ACCC03870 and Gram-negative Pseudomonas fluorescens ATCC13525, which were linked to food spoilage and several diseases [42,43] via membrane breaking, metabolic dysfunction, DNA disruption, and interrupting cellular function. Insects such as the maize weevil (Sitophilus zeamais) can devastate entire crops, particularly grains [44]; however, (+)-3-carene has reportedly been used as an effective pest control fumigant to address this problem [41]. Further, this compound is not only an effective microbe and insect inhibitor but also enhances the quality and duration of sleep in animals by interacting with GABAA-benzodiazepine receptors (Figure 1) [20].

2.2. Camphene

Camphene is a monoterpene that is also referred to as comphene, 79–92–5, and 2,2-dimethyl-3-methylenenorbornane [45]. Camphene inhibits the growth of Paracoccidioides lutzii, a fungus that causes paracoccidioidomycosis [46], through protease inhibition and the dysregulation of important biological pathways [47]. Further, this compound induced the death of the old-world bollworm (Helicoverpa armigera) the eggs of which were dipped [48]. Regarding its therapeutic properties, this compound decreases the level of serum lipids such as cholesterol and triglycerides by upregulating sterol regulating binding protein-1 (SREBP-1) and downregulating MTP expression [21] while leaving the expression of 3-dydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase largely unaffected [49]. Further, this compound decreased the oxidative stress on respiratory macrophages by preventing the upregulation of superoxide dismutase (SOD) and reducing glutathione (GSH) levels, in addition to decreasing the levels of lipid peroxidation and nitric oxide (NO) [50], thus stimulating tumor cell death via endoplasmic reticulum stress (Figure 2) [22].

2.3. Camphor

Camphor is a monoterpene that is also referred to as camphor gum, (1R)-camphor, and 464–49–3 [51]. Many tropical diseases such as malaria, dengue, and elephantiasis are caused by mosquito bites. A total of 434,000 mosquito-borne diseases were reported worldwide in 2015, thus highlighting the serious threat that these insects pose to human health [52]. Camphor has been used as a mosquito repellent in topical application, cosmetics, incense, fumigants, or sprays [53] and to inhibit the growth of some pathogenic microorganisms such as Candida albicans, a representative opportunistic pathogenic yeast that causes severe health complications, particularly in immunodeficient or cancer patients [54]. This compound also inhibits the growth of Staphylococcus aureus, a Gram-positive bacterium linked to skin abscesses and food poisoning [55], and Pseudomonas aeruginosa, an opportunistic Gram-negative pathogenic bacterium that infects plants and animals including humans [56] and has reportedly acquired mulita-antibiotic resistance [57]. Camphor alters cold and heat perception by modulating blood flow in the skin and muscles [58]. Particularly, cold perception is regulated by transient receptor potential melastatin 8 (TRPM8) [59], whereas heat perception is modulated by transient receptor potential vanilloid 3 (TRPV3) (Figure 3) [60].

2.4. 1,8-Cineol

1,8-cineol is a monoterpene and there are many synonyms for this compound including eucalyptol, zineol, trepan, and zedoary oil, among others [61]. In 1870, Cloez reported that 1,8-cineol accounted for 90% of the total composition of Eucalyptus globulus oil [62]. This compound has many therapeutic properties, such as protective effects against the influenza A virus, which induces pneumonia through cytokine modulation and the NF-κB pathway [63], as well as anti-cancer effects via G0/G1 arrest [64], anti-asthmatic effect through mucolysis, downregulation of TNF-α and IL-1β, inactivation of the NF-κB and TLR4 pathways [64,65,66,67], and anti-inflammatory and anti-oxidative effects via inhibition of NF-κB translocation and the JNK pathway (Figure 4) [68].

2.5. p-Cymene

There are many synonyms for p-cymene, including 1-isopropyl-4-methylbenzene, p-cimene, 4-isopropyltoluene, and camphogen [69]. This monoterpene has several biological effects, such as downregulating of both pathological Gram-positive bacteria such as Staphylococcus aureus, Streptococcus mutans, and Streptococcus sanguinis, as well as pathological Gram-negative bacteria such as Escherichia coli O157:H7, Vibrio parahaemolyticus, and Salmonella enterica [70]. Particularly, this compound regulates oxidative stress-induced factors such as thiobarbituric acid reactive substances (TBARS), nitrite, and catalase (CAT) activity [71]; inhibits inflammation via NF-κB pathway [72,73], promotes sleep through the GABAergic pathway [74]; and suppresses cancer proliferation and cancer-associated pain (Figure 5) [75] via apoptosis and autophagy [23].

2.6. Limonene

Limonene is another monoterpene whose synonyms include eulimen, dipentene, nesol, goldflush II, cajeputene, and dipanol [76]. This compound effectively controls Listeria monocytogenes, a food poisoning-associated microbe, by disrupting its cell membrane and decreasing ATP activity [77]. Further, it prevents Aβ42-induced neurotoxicity in a Drosophila Alzheimer’s disease model by eliminating H2O2 and nitric oxide-induced inflammation and cell death [26]. This compound also prevents reactive oxygen species (ROS)-induced gastritis by both downregulating proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 and upregulating the anti-inflammatory cytokine IL-10 [78]. Limonene has also been reported to modulate depressive behaviors by suppressing psychostimulant and monoamine neurotransmitters, in addition to inhibiting both neurotrophic factor release and its receptor activation [79], as well as the proliferation of cancer cells via the stimulation of apoptosis (Figure 6) [80].

2.7. Linalool

Linalool is a monoterpene that is also widely known as coriandrol, howood oil, allo-ocimenol, caswell No. 526A, and phantol [81]. It has antifungal effects against dermatophytes such as Microsporum spp. and Trichophyton spp. and has synergic effects when combined with azole [82]. Moreover, this compound promotes operant behavior through the GABA receptor [83], is used as an ingredient for perfume and cosmetics with anti-oxidative effects and low cytotoxicity [84], prevents ovalbumin-induced asthma occurrence by inhibiting airway remodeling [85], and decreases oxidative stress-induced cell death by regulating glutamate metabolism in the cornu ammonis 1 and 3 and dentate gyrus in the hippocampal regions of the brain (Figure 7) [27].

2.8. Myrcene

Myrcene is a monoterpene that is also known as MFCD00008908, FEMA No. 2762, CCRIS 3725, β-geraniolene, and β-mircene [86]. It controls cystic echinococcosis via morphological alteration in Echinococcus granulosus larval cells [87], attenuates pain through TRPV1 regulation [88], prevents ovalbumin-induced neonatal asthma by controlling pulmonary matrix changes [29], inhibits glucocorticoid malfunction-induced renal impairment, which is caused by oxidative stress and inflammation [28], protects against MMP synthesis caused by UVB-induced ROS and IL-6 expression, and reverts UVB-induced TGF-β1 down-regulation (Figure 8) [89].

2.9. α-Phellandrene

α-phellandrene is a monoterpene that is also known as ZINC8418983, p-mentha-1,5-diene, (5S)-5-isopropyl-2-methylcyclohexa-1,3-diene, CHEB:367, and Q25933668 [90]. α-phellandrene has been used to control insect pests on larvae under dipping or on adults under topical application such as the southern house mosquito (Culex quinquefasciatus), the African cotton leafworm (Spodoptera littoralis), and the common housefly (Musca domestica) [91]. This compound also inhibits the proliferation of bacteria such as Staphylococcus pneumoniae, Vibrio cholerae, and Escherichia coli, as well as fungi such as Fusarium moniliforme [92], and promotes the recovery of skin wounds by reducing oxidative stress-induced inflammation and stimulating fibroblast activity (e.g., migration and proliferation) (Figure 9) [93].

2.10. Pinene

Pinene consists of two isomers including α-pinene and β-pinene [94]. α-pinene and β-pinene have many therapeutic properties such as antimicrobial activity, anti-proliferation effects against cancer cells, antioxidation, and anti-inflammation [95], in addition to gastroprotective activity by modulating gastrointestinal transitional time [96], as well as synergistic effects against the proliferation of non-small cell lung carcinoma (NSCLC) when co-administered with paclitaxel (Figure 10) [97].

2.10.1. α-Pinene

α-pinene has many therapeutic properties, such as antiviral effects against herpes simplex virus type 1 (HSV-1) [98], modulation of antibiotic resistance in Campylobacter jejuni through antibiotic efflux down-regulation [99], apoptosis induction in cancer cells via ROS production, mitochondrial malfunction, caspase cascade activation, and inhibition of metastasis [100]. Additionally, this compound mediates sleep-enhancement-induced hypnosis through GABAA-benzodiazepine receptor modulation [101], and preventive and therapeutic effects against allergic rhinitis via the regulation of disease-related factors such as IgE, IL-4, NF-κB, and receptor-interacting protein 2 (RIP2), as well as eosinophils infiltration in the lungs [102].

2.10.2. β-Pinene

Although the chemical formula of β-pinene is the same as that of its isomer α-pinene, the former possesses unique biological properties. For instance, β-pinene attenuates Cr-induced phytotoxicity due to its antioxidant properties [103] and possesses antifungal and anti-biofilm properties against Candida spp. [104]. This compound also suppresses hypertension via Ca2+ influx inhibition-mediated vasorelaxation [105] and has antiviral effects against herpes simplex virus type 1 (HSV-1) [106].

2.11. α-Terpinen

α-terpinen is a monoterpene that is also known as p-mentha-1,3-diene, terpilene, FEMA No. 3558, CCRIS 9058, Tox21_301126, and ZINC967593 [107]. This compound has anti-parasitic activity against Trypanosoma evansi when used in oral treatment or intraperitoneal injection and increases the life expectancy of infected animals [31]. Similar to α-pinene, α-terpinen has antiviral effects against HSV-1 by decreasing infection rate and selectivity to the virus [106]. Additionally, this compound has antispasmodic activity in the trachea [108] and blocks antibiotic-resistance in Staphylococcus aureus through NorA efflux-pump inactivation (Figure 11) [109].

2.12. Terpinolene

The monoterpene terpinolene is also known as tereben, p-Menth-1,4(8)-diene, isoterpinene, Nofmer TP, and 1,4(8)-terpadiene [110]. Terpinolene makes Staphylococcus aureus more susceptible to antibiotics by inactivating the resistance-mediated quaternary ammonium compounds C (QacC) efflux pump and β-lactamases [111]. Additionally, this compound has wound-healing effects [93], acts as a relaxant when inhaled [112], decelerates brain tumor growth and oxidative stress [25], controls the proliferation of Microcystis aeruginosa through (1) upregulation of reactive oxygen species (ROS) and malondialdehyde (MDA) to activate photosynthesis, (2) inhibition of the activities of important biological enzymes, e.g., nitrate reductase (NR) for protein synthesis and glutamine synthetase (GS) for the production of glutamate, and (3) upregulation of ATP-binding cassette transporters (ABC transporter), which are induced by ions and xenobiotics [113], as well as cytochrome c oxidase subunit II (COX II), which participates in ATP regulation [114] in the plasma membrane (Figure 12) [115].

3. NVOC Safety

Despite the promising health-promoting properties of NVOCs, their safety must be thoroughly assessed prior to their implementation as pharmaceutical candidates or dietary supplements. NVOCs are used in a variety of products, such as cosmetic materials (e.g., soap, perfume, lotion), flavor agents, aromatherapy, additives in several food products (i.e., baked goods, frozen dairy, gelatins), and vector repellents [20,22,23,24,25,26,27,28,31,41,62,84,89]; however, their safe use is highly regulated. NVOCs can induce toxic effects depending on their dose and, therefore, toxicology studies are critical (Table 1). (+)-3-carene irritates the lungs and central nervous system (CNS) [33], camphor irritates the gastrointestinal tract and CNS [116], and 1,8-cineol induces genotoxicity via oxidative DNA damage [35]. p-cymene is thought to be less toxic, but it induces neurochemical abnormalities after four weeks of inhalation [117]. Limonene has been found to induce hepatotoxicity and neurotoxicity [36] and oxidized forms of limonene and linalool induce allergic reactions in the skin [37]. The toxicity of myrcene has long been the topic of much debate due to its potential genotoxicity or nephrotoxicity and, therefore, the US FDA prohibited its use as a food additive [118]. Further, oxidized α-phellandrene and oxidized terpinolene induce contact allergy [38], α-pinene induces pulmonary inflammation [119], β-pinene can irritate the skin and mucous systems [120], whereas α-terpinene has embryo/fetotoxic effects [121]. In order to use NVOCs as pharmaceutical candidates or dietary supplements, we should use them in quantities the enormous volume needs. Then, the level of them in the forest should be analyzed and they should be collected from the air or from the extracts. All of the 12 NVOCs which are discussed in this review could be analyzed by gas chromatography-mass spectrometry (GC-MS) based on their biological characters [122,123,124,125].

4. Perspectives

NVOCs are promising modulators of disease, as each NVOC has a potency to control diseases such as insomnia via sleep-enhancing by (+)-3-carene [20], cancer proliferation via induction of cancer cells’ apoptosis by camphene [22], microbial infection by camphor [54], chronic disease through suppression of oxidative stress and inflammation and asthma/COPD via modulation of NF-κB activation and TNF-α secretion by 1,8-cineol [64,65,66,67], cancer proliferation via cancer cells’ death and cancer pain by p-cymene [75], mental disorder via antidepressant-like effects of limonene [79], allergy through controlling MAPKs/NF-κB pathway by linalool [85], pain via TRPV1 regulation by myrcene [88], skin damage through controlling inflammation by α-phellandrene [93], allergic rhinitis through NF-κB controlling and caspase pathway by α-pinene [100], hypertension via modulation of Ca2+ influx by β-pinene [105], antibiotic-resistance of Staphylococcus aureus through NorA efflux pump inactivation by α-terpinene [109], and Microcystis aeruginosa propagation through induction oxidative stress and carbonyl stress by terpinolene [115]. However, characterizing the mechanisms by which NVOCs inhibit disease progression is critical for their wide application in clinical contexts. NVOCs can be administered either directly (e.g., oral administration, inhalation) or indirectly using a syringe, nebulizer, or patch. However, oral administration and inhalation are more convenient to the patients and caregivers (e.g., nurses, doctors). Most NVOCs have relatively low boiling points, thus facilitating their administration via inhalation. This is an important advantage, as it enables the administration of therapeutic compounds without the need for highly specialized equipment.
Nevertheless, the safety of NVOCs must also be carefully evaluated to ensure their safety. Paracelsus [126] is credited for stating that “the dose makes the poison,” meaning that virtually all compounds can be toxic if administered at high enough doses.
Currently, most drugs and therapeutic compounds can be chemically synthesized [127], and NVOCs are no exception. However, artificially synthesized and natural NVOCs could have different physiological effects. For example, myrcene has been long used as a food additive and a flavoring agent or adjuvant due to its pleasant aroma; however, its safety has been debated for several years. In 2010 the National Toxicology Program (NTP) reported that β-myrcene could induce renal carcinogenesis in mice and rats [128]. Nevertheless, the FDA ultimately determined that β-myrcene did not induce genotoxicity. Moreover, although this compound was linked to renal carcinogenesis in laboratory animals, some speculated that the compound was safe for human use as a synthetic food additive. Nevertheless, the FDA prohibited the use of synthetic β-myrcene as a food additive in 2018 [129]. This case serves as a precedent for the use of NVOCs (particularly those of natural origin) in medications and food products. Nevertheless, the current changes in climate conditions could induce an increase in NVOC concentrations in plants as a stress response mechanism, which might increase the likelihood of toxic effects. Therefore, future studies should focus on the dose-dependent toxicity of NVOCs.

Funding

This research and the APC were funded by R&D Program for Forest Science Technology (Korea Forest Service, Korea Forestry Promotion Institute), grant number 2019148A00−1921−AB02.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Health Canada. Available online: http://www.hc-sc.gc.ca/ewh-semt/pubs/air/office_building-immeubles_bureaux/organic-organiques-eng.php (accessed on 26 August 2021).
  2. European Solvents Downstream Users Coordination Group. How Are Solvents Regulated? Why Do Products Contain VOC Solvents? And Why Do We (Still) Use Them? Focus: Solvents and VOCs. Available online: https://www.esig.org/wp-content/uploads/2020/04/VOC_IAQ_final_202002.pdf (accessed on 26 August 2021).
  3. The National Institute of Standards and Technology Home Page. Available online: http://cpcb.nic.in/displaypdf.php?id=aG9tZS9haXItcG9sbHV0aW9uL05vLTE0LTE5ODEucGRm (accessed on 29 July 2021).
  4. Definitions of VOC and ROG; California Air Resources Board: Sacramento, CA, USA, November 2004.
  5. Holopainen, J.K.; Gershenzon, J. Multiple stress factors and the emission of plant VOCs. Trends Plant. Sci. 2010, 15, 176–184. [Google Scholar] [CrossRef] [PubMed]
  6. Furstenberg-Hagg, J.; Zagrobelny, M.; Bak, S. Plant defense against insect herbivores. Int. J. Mol. Sci. 2013, 14, 10242–10297. [Google Scholar] [CrossRef] [Green Version]
  7. Tahir, H.A.S.; Gu, Q.; Wu, H.; Raza, W.; Hanif, A.; Wu, L.; Colman, M.V.; Gao, X. Plant growth promotion by volatile organic compounds produced by Bacillus subtilis SYST2. Front. Microbiol. 2017, 8, 171. [Google Scholar] [CrossRef] [Green Version]
  8. Llusia, J.; Penuelas, J.; Gimeno, B. Seasonal and species-specific response of VOC emissions by Mediterranean woody plant to elevated ozone concentrations. Atmos. Environ. 2002, 36, 3931–3938. [Google Scholar] [CrossRef]
  9. Niederbacher, B.; Winkler, J.B.; Schnitzler, J.P. Volatile organic compounds as non-invasive markers for plant phenotyping. J. Exp. Botany. 2015, 66, 5403–5416. [Google Scholar] [CrossRef]
  10. Penuelas, J.; Llusia, J. The complexity of factors driving volatile organic compound emissions by plants. Biol. Plant. 2001, 44, 481–487. [Google Scholar] [CrossRef]
  11. Pichersky, E.; Gershenzon, J. The formation and function of plant volatiles: Perfumes for pollinator attraction and defense. Curr. Opin. Plant. Biol. 2002, 5, 237–243. [Google Scholar] [CrossRef]
  12. Hansen, U.; Seufert, G. Temperature and light dependence of beta-caryophyllene emission rates. J. Geophys. Res. Atmos. 2003, 108, 4801. [Google Scholar] [CrossRef]
  13. Sharkey, T.D.; Loreto, F. Water stress, temperature, and light effects on the capacity for isoprene emission and photosynthesis of Kudzu leaves. Oecologia 1993, 95, 328–333. [Google Scholar] [CrossRef]
  14. Staudt, M.; Seufert, G. Light-dependent emission of monoterpenes by holm oak (Quercus ilex L). Naturwissenschaften 1995, 82, 89–92. [Google Scholar] [CrossRef]
  15. Ebel, R.C.; Mattheis, J.P.; Buchanan, D.A. Drought stress of apple-trees alters leaf emissions of volatile compounds. Physiol. Plant. 1995, 93, 709–712. [Google Scholar] [CrossRef]
  16. Vallat, A.; Gu, H.; Dorn, S. How rainfall, relative humidity and temperature influence volatile emissions from apple trees in situ. Phytochemistry 2005, 66, 1540–1550. [Google Scholar] [CrossRef] [PubMed]
  17. Loreto, F.; Delfine, S. Emission of isoprene from salt-stressed Eucalyptus globulus leaves. Plant. Physiol. 2000, 123, 1605–1610. [Google Scholar] [CrossRef] [Green Version]
  18. Heiden, A.C.; Hoffmann, T.; Kahl, J.; Kley, D.; Klockow, D.; Langebartels, C.; Mehlhorn, H.; Sandermann, H., Jr.; Schraunder, M.; Schuh, G.; et al. Emission of volatile organic compounds from ozone-exposed plants. Ecol. Appl. 1999, 9, 1160–1167. [Google Scholar] [CrossRef]
  19. Vuorinen, T.; Nerg, A.M.; Holopainen, J.K. Ozone exposure triggers the emission of herbivore-induced plant volatiles, but dose not disturb tritrophic singalling. Environ. Pollut. 2004, 131, 305–311. [Google Scholar] [CrossRef] [PubMed]
  20. Woo, J.; Yang, H.; Yoon, M.; Gadhe, C.G.; Pae, A.N.; Cho, S.; Lee, C.J. 3-Carene, a phytoncide from pine tree has a sleep-enhancing effect by targeting the GABAA-benzodiazepine receptors. Exp. Neurobiol. 2019, 28, 593–601. [Google Scholar] [CrossRef] [Green Version]
  21. Vallianou, I.; Hadzopoulou-Cladaras, M. Camphene, a plant derived monoterpene, exerts its hypolipidemic action by affecting SREBP-1 and MTP expression. PLoS ONE 2016, 11, e0147117. [Google Scholar] [CrossRef] [Green Version]
  22. Girola, N.; Figueiredo, C.R.; Farias, C.F.; Azevedo, R.A.; Ferreira, A.K.; Teixeira, S.F.; Capello, T.M.; Martins, E.G.A.; Matsuo, A.L.; Travassos, L.R.; et al. Camphene isolated from essential oil of Piper cernuum (Piperaceae) induces intrinsic apoptosis in melanoma cells and displays antitumor activity in vivo. Biochem. Biophys. Res. Commun. 2015, 467, 928–934. [Google Scholar] [CrossRef] [PubMed]
  23. Lenis-Rojas, O.A.; Robalo, M.P.; Tomaz, A.I.; Carvalho, A.; Fernandes, A.R.; Marques, F.; Folgueira, M.; Yanez, J.; Vazquez-Garcia, D.; Torres, M.L.; et al. RuII(p-cymene) compounds as effective and selective anticancer candidates with no toxicity in vivo. Inorgan. Chem. 2018, 57, 13150–13166. [Google Scholar] [CrossRef]
  24. Hou, J.; Zhang, Y.; Zhu, Y.; Zhou, B.; Ren, C.; Liang, S.; Guo, Y. α-pinene induces apoptotic cell death via caspase activation in human ovarian cancer cells. Med. Sci. Monit. 2019, 25, 6631–6638. [Google Scholar] [CrossRef] [PubMed]
  25. Aydin, E.; Turkez, H.; Tasdemir, S. Anticancer and antioxidant properties of terpinolene in rat brain cells. Arh. Hig. Rada. Toksikol. 2013, 64, 415–424. [Google Scholar] [CrossRef] [PubMed]
  26. Shin, M.; Liu, Q.F.; Choi, B.; Shin, C.; Lee, B.; Yuan, C.Y.; Song, J.; Yun, H.S.; Lee, I.-S.; Koo, B.-S.; et al. Neuroprotective effects of limonene (+) against Aβ42-induced neurotoxicity in a Drosophila model of Alzheimer’s disease. Biol. Pharm. Bull. 2020, 43, 409–417. [Google Scholar] [CrossRef] [Green Version]
  27. Sabogal-Guaqueta, A.M.; Hobbie, F.; Keerthi, A.; Oun, A.; Kortholt, A.; Boddeke, E.; Dogla, A. Linalool attenuates oxidative stress and mitochondrial dysfunction mediated by glutamate and NMDA toxicity. Biomed. Pharmacother. 2019, 118, 10295. [Google Scholar] [CrossRef] [PubMed]
  28. Islam, A.U.S.; Hellman, B.; Nyberg, F.; Amir, N.; Jayaraj, R.L.; Petroianu, G.; Adem, A. Myrcene attenuates renal inflammation and oxidative stress in the adrenalectomized rat model. Molecules 2020, 25, 4492. [Google Scholar] [CrossRef]
  29. Du, Y.; Luan, J.; Jiang, R.P.; Liu, J.; Ma, Y. Myrcene exerts anti-asthmatic activity in neonatal rats via modulating the matrix remodeling. Immunopathol. Pharmacol. 2020, 34, 1–10. [Google Scholar] [CrossRef] [PubMed]
  30. Kumar, A.; Agarwal, K.; Singh, M.; Saxena, A.; Yadav, P.; Maurya, A.K.; Yadav, A.; Tandon, S.; Chanda, D.; Bawankule, D.U. Essential oil from waste leaves of Curcuma longa L. alleviates skin inflammation. Inflammopharmacology 2018, 26, 1245–1255. [Google Scholar] [CrossRef] [PubMed]
  31. Baldissera, M.D.; Grando, T.H.; Souza, C.F.; Gressler, L.T.; Stefani, L.M.; de Silva, A.S.; Monteiro, S.G. In vitro and in vivo action of terpinen-4-ol, γ-terpinene, and α-terpinene against Trypanosoma evansi. Exp. Parasiol. 2016, 162, 43–48. [Google Scholar] [CrossRef]
  32. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov (accessed on 29 July 2021).
  33. Falk, A.; Lof, A.; Hagberg, M.; Hjelm, E.W.; Wang, Z. Human exposure to 3-carene by inhalation: Toxicokinetics, effects on pulmonary function and occurrence of irritative and CNS symptoms. Toxicol. Appl. Pharm. 1991, 110, 198–205. [Google Scholar] [CrossRef]
  34. Schlumpf, M.; Durrer, S.; Faass, O.; Ehnes, C.; Fuetsch, M.; Gaille, C.; Henseler, M.; Hofkamp, L.; Maerkel, K.; Reolon, S.; et al. Developmental toxicity of UV filters and environmental exposure: A review. Int. J. Androl. 2008, 31, 144–151. [Google Scholar] [CrossRef]
  35. Dorsam, B.; Wu, C.F.; Efferth, T.; Kaina, B.; Fahrer, J. The eucalyptus oil ingredient 1,8-cineol induces oxidative DNA damage. Arch. Toxicol. 2015, 89, 797–805. [Google Scholar] [CrossRef]
  36. Ravichandran, C.; Badgujar, P.; Gundev, P.; Upadhyay, A. Review of toxicological assessment of d-limonene, a food and cosmetics additive. Food. Chem. Toxicol. 2018, 120, 668–680. [Google Scholar] [CrossRef]
  37. Audrain, H.; Kenward, C.; Lovell, C.R.; Green, C.; Ormerod, A.D.; Sansom, J.; Chowdhury, M.M.U.; Cooper, S.M.; Johnston, G.A.; Wilkinson, M.; et al. Allergy to oxidized limonene and linalool is frequent in the U.K. Br. J. Dermatol. 2014, 171, 292–297. [Google Scholar] [CrossRef] [PubMed]
  38. de Groot, A.C.; Schmidt, E. Tee tree oil: Contact allergy and chemical composition. Contact Dermatitis 2016, 75, 129–143. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/443156 (accessed on 29 July 2021).
  40. Shu, H.; Chen, H.; Wang, X.; Hu, Y.; Yun, Y.; Zhong, Q.; Chen, W.; Chen, W. Antimicrobial activity and proposed action mechanism of 3-carene against Brochothrix thermosphacta and Pseudomonas fluorescens. Molecules 2019, 24, 3246. [Google Scholar] [CrossRef] [Green Version]
  41. Langsi, J.D.; Nukenine, E.N.; Oumarou, K.M.; Moktar, H.; Fokunang, C.N.; Mbata, G.N. Evaluation of the insecticidal activities of α-pinene and 3-carene on Sitophilus zeamais motschulsky (Coleoptera: Curculionidae). Insects 2020, 11, 540. [Google Scholar] [CrossRef] [PubMed]
  42. Illikoud, N.; Jaffres, E.; Zagorec, M. Bronchothrix thermosphacta. In Reference Module in Life Sciences; Elsevier: Amsterdam, The Netherlands, 2018. [Google Scholar]
  43. Ray, B.; Bhunia, A. Fundamental Food Microbiology; CRC Press: Boca Raton, FL, USA, 2004; Volume 64, p. 33. [Google Scholar]
  44. Nukenine, E.N. Stored product pests. Jul. –Kuhn-Arch. 2010, 425, 26–41. [Google Scholar]
  45. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/6616 (accessed on 29 July 2021).
  46. Queiroz-Telles, F.; Fahal, A.H.; Falci, D.R.; Caceres, D.H.; Chiller, T.; Pasqualotto, A.C. Neglected endemic mycoses. Lancet Infect. Dis. 2017, 17, e367–e377. [Google Scholar] [CrossRef]
  47. Silva, K.S.F.E.; Neto, B.R.D.S.; Zambuzzi-Carvalho, P.F.; Oliveira, C.M.D.; Pires, L.B.; Kato, L.; Bailao, A.M.; Parente-Rocha, J.A.; Hernandez, O.; Ochoa, J.G.M.; et al. Response of Paracoccidioides lutzii to the antifungal camphene thiosemicarbazide determined by proteomic analysis. Future. Microbiol. 2018, 13, 1473–1496. [Google Scholar] [CrossRef]
  48. Benelli, G.; Govindarajan, M.; Rajeswary, M.; Vaseeharan, B.; Alyahya, S.A.; Alharbi, N.S.; Kadaikunnan, S.; Khaled, J.M.; Maggi, F. Insecticidal activity of camphene, zerumbone and α-humulene from Cheilocostus speciosus rhizome essential oil against the Old-World bollworm, Helicoverpa armigera. Ectoxicol. Environ. Saf. 2018, 148, 781–786. [Google Scholar] [CrossRef]
  49. Vallianou, I.; Peroulis, N.; Pantazis, P.; Hadzopoulou-Cladaras, M. Camphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-coA reductase activity. PLoS ONE 2011, 6, e20516. [Google Scholar] [CrossRef] [Green Version]
  50. Tiwari, M.; Kakkar, P. Plant derived antioxidnats−geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress. Toxicol In Vitro 2009, 23, 295–301. [Google Scholar] [CrossRef]
  51. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/230921 (accessed on 29 July 2021).
  52. Impact of Mosquito-Borne Diseases Worldwide in 2015. Available online: https://www.statista.com/statistics/515118/mosquito-borne-diseases-global-impact (accessed on 29 July 2021).
  53. Pohlit, A.M.; Lopes, N.P.; Gama, R.A.; Tadei, W.P.; de Andrade Neto, V.F. Patent literature on mosquito repellent inventions which contain plant essential oils−a review. Planta Med. 2011, 77, 598–617. [Google Scholar] [CrossRef] [Green Version]
  54. Lischewski, A.; Harmsen, D.; Wilms, K.; Baier, G.; Gunzer, U.; Klinker, H.; Wilhelm, M.; Schwinn, A.; Hacker, J. Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique. Mycoses. 1999, 42, 371–383. [Google Scholar] [CrossRef]
  55. Xu, S.X.; McCormick, J.K. Staphylococcal superantigens in colonization and disease. Front. Cell. Infect. Microbiol. 2012, 2, 52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Diggle, S.; Whitely, M. Microbe profile: Pseudomonas aeruginosa: Opportunistic pathogen and lab rat. Microbiology. 2020, 166, 30–33. [Google Scholar] [CrossRef]
  57. Poole, K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 2004, 10, 12–26. [Google Scholar] [CrossRef] [Green Version]
  58. Kotaka, T.; Kimur, S.; Kashiwayanagi, M.; Iwamoto, J. Camphor induces cold and warm sensations with increases in skin and muscle blood flow in human. Biol. Pharm Bull. 2014, 37, 1913–1918. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Selescu, T.; Ciobanu, A.C.; Dobre, C.; Reid, G.; Babes, A. Camphor activates and sensitizes transient receptor potential melastatin 8 (TRPM8) to cooling and icilin. Chem. Senses. 2013, 38, 563–575. [Google Scholar] [CrossRef]
  60. Steinhoff, M.; Biro, T. A TR(I)P to pruritus research: Role of TRPV3 in inflammation and itch. J. Invet. Dermatol. 2009, 129, 531–535. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/2758 (accessed on 29 July 2021).
  62. Boland, D.J.; Brophy, J.J.; House, A.P.N. Eucalyptus Leaf Oils: Use, Chemistry, Distillation and Marketing; Inkata Press: Melbourne, Australia, 1991; p. 6. [Google Scholar]
  63. Li, Y.; Lai, Y.; Wang, Y.; Liu, N.; Zhang, F.; Xu, P. 1,8-cineol protect against influenza-virus-induced pneumonia in mice. Inflammation 2016, 39, 1582–1593. [Google Scholar] [CrossRef]
  64. Rodenak-Kladniew, B.; Castro, A.; Starkel, P.; Galle, M.; Crespo, R. 1,8-cineole promotes G0/G1 cell cycle arrest and oxidative stress-induced senescence n HepG2 cells and sensitizes cells to anti-senescence drugs. Life Sci. 2020, 243, 117271. [Google Scholar] [CrossRef]
  65. Juergens, L.J.; Worth, H.; Juergens, U.R. New perspectives for mucolytic, anti-inflammatory and adjunctive therapy with 1,8-cineole in COPD and asthma: Review on the new therapeutic approach. Adv. Ther. 2020, 37, 1737–1753. [Google Scholar] [CrossRef] [Green Version]
  66. Juergens, U.R.; Engelen, T.; Racke, K.; Stober, M.; Gillissen, A.; Vetter, H. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulm. Pharmacol. Ther. 2004, 17, 281–287. [Google Scholar] [CrossRef] [PubMed]
  67. Zhao, C.; Sun, J.; Fang, C.; Tang, F. 1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice. Inflammation 2014, 37, 566–572. [Google Scholar] [CrossRef] [PubMed]
  68. Greiner, J.F.W.; Muller, J.; Zeuner, M.-T.; Hauser, S.; Seidel, T.; Klenke, C.; Grunwald, L.-M.; Schomann, T.; Widera, D.; Sudhoff, H.; et al. 1,8-cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity. Biochim. Biophy. Acta 2013, 1833, 2866–2878. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/7463 (accessed on 29 July 2021).
  70. Yang, T.-S.; Chao, L.K.-P.; Liu, T.-T. Antimicrobial activity of the essential oil of Glossogyne tenuifolia against selected pathogens. J. Sci. Food Agric. 2014, 94, 2965–2971. [Google Scholar] [CrossRef]
  71. de Oliveira, T.M.; de Carvalho, R.B.F.; da Costa, I.H.F.; de Oliveira, G.A.L.; de Souza, A.A.; de Lima, S.G.; de Freitas, R.M. Evaluation of p-cymene, a natural antioxidant. Pharm. Biol. 2015, 53, 423–428. [Google Scholar] [CrossRef]
  72. Xie, G.; Chen, N.; Soromou, L.W.; Liu, F.; Xiong, Y.; Wu, Q.; Li, H.; Feng, H.; Liu, G. p-cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Molecules 2012, 17, 8159–8173. [Google Scholar] [CrossRef] [Green Version]
  73. Zhong, W.; Chi, G.; Jiang, L.; Soromou, L.W.; Chen, N.; Huo, M.; Guo, W.; Deng, X.; Feng, H. p-cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation. Inflammation 2013, 36, 529–537. [Google Scholar] [CrossRef]
  74. Dougnon, G.; Ito, M. Role of ascaridole and p-cymene in the sleeping-promoting effects of Dysphania ambrosioides essential oil via the GABAergic system in a ddY mouse inhalation model. J. Nat. Prod. 2021, 84, 91–100. [Google Scholar] [CrossRef]
  75. Santos, W.B.R.; Melo, M.A.O.; Alves, R.S.; Brito, R.G.D.; Rabelo, T.K.; Prado, L.D.S.; Silva, V.K.D.S.; Bezerra, D.P.; Menezes-Filho, J.E.R.D.; Souza, D.S.; et al. p-cymene attenuates cancer pain via inhibitory pathways and modulation of calcium currents. Phytomed. 2019, 61, 152836. [Google Scholar] [CrossRef] [PubMed]
  76. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/22311 (accessed on 29 July 2021).
  77. Han, Y.; Sun, Z.; Chen, W. Antimicrobial susceptibility and antibacterial mechanism of limonene against Listeria monocytogenes. Molecules 2020, 25, 33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. de Souza, M.C.; Vieira, A.J.; Beserra, F.P.; Pellizzon, C.H.; Nobrega, R.H.; Rozza, A.L. Gastroprotective effect of limonene in rats: Influence on oxidative stress, inflammation and gene expression. phytomedicine. 2019, 53, 37–42. [Google Scholar] [CrossRef] [PubMed]
  79. Zhang, L.L.; Yang, Z.-Y.; Fan, G.; Ren, J.-N.; Yin, K.-J.; Pan, S.-Y. Antidepressant-like effect of Citrus sinensis (L.) osbeck essential oil and its main component limonene on mice. J. Agric. Food Chem. 2019, 67, 13817–13828. [Google Scholar] [CrossRef] [PubMed]
  80. Shojaei, S.; Kiumarsi, A.; Moghadam, A.R.; Alizadeh, J.; Marzban, H.; Ghavami, S. Perillyl alcohol (monoterpene alcohol), limonene. Enzymes 2014, 36, 7–32. [Google Scholar]
  81. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/6549 (accessed on 29 July 2021).
  82. Ponte, H.A.S.; Lima, M.I.D.O.; Lima, E.D.O.; Pereira, F.D.O. Linalool modulates dermatophyte susceptibility to azole drugs. Med. Mycol. 2019, 0, 1–3. [Google Scholar] [CrossRef] [PubMed]
  83. Shaw, D.; Norwood, K.; Kennedy, P.J.; Leslie, J.C. Effects of linalool on extinction of mouse operant behavior. Behav. Pharmacol. 2020, 31, 73–80. [Google Scholar] [CrossRef]
  84. Yingngam, B.; Brantner, A.H. Factorial design of essential oil extraction from Fagraea fragrans Roxb. Flowers and evaluation of its biological activities for perfumery and cosmetic applications. Int. J. Cosmet. Sci. 2015, 37, 272–281. [Google Scholar] [CrossRef]
  85. Kim, M.-G.; Kim, S.-M.; Min, J.-H.; Kwon, O.-K.; Park, M.-H.; Park, J.-W.; Ahn, H.I.; Hwang, J.-Y.; Oh, S.-R.; Lee, J.-W.; et al. Anti-inflammatory effects of linalool on ovalbumin-induced pulmonary inflammation. Int. Immunopharm. 2019, 74, 105706. [Google Scholar] [CrossRef]
  86. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/31253 (accessed on 29 July 2021).
  87. Fabbri, J.; Maggiore, M.A.; Pensel, P.E.; Albani, C.M.; Denegri, G.M.; Elissondo, M.C. Could beta-myrcene be an alternative to albendazole for the treatment of experimental cystic echinococcosis? Acta Trop. 2018, 187, 5–12. [Google Scholar] [CrossRef]
  88. Jansen, C.; Shimoda, L.M.N.; Kawakami, J.K.; Ang, L.; Bacani, A.J.; Baker, J.D.; Badowski, C.; Speck, M.; Stokes, A.J.; Small-Howard, A.L.; et al. Myrcene and terpene regulation of TRPV1. Channels 2019, 13, 344–366. [Google Scholar] [CrossRef] [Green Version]
  89. Hwang, E.; Ngo, H.T.T.; Park, B.; Seo, S.-A.; Yang, J.E.; Yi, T.-H. Myrcene, an aromatic volatile compound, ameliorates human skin extrinsic aging via regulation of MMPs production. Am. J. Chin. Med. 2017, 45, 1–12. [Google Scholar] [CrossRef] [PubMed]
  90. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/443160 (accessed on 29 July 2021).
  91. Pavela, R.; Maggi, F.; Cianfaglione, K.; Canale, A.; Benelli, G. Promising insecticidal efficacy of the essential oils from the halophyte Echinophora spinosa (Apiaceae) growing in Corsica Island, France. Environ. Sci. Pollut. Res. Int. 2020, 27, 14454–14464. [Google Scholar] [CrossRef] [PubMed]
  92. Canales-Martinez, M.; Rivera-Yanez, C.R.; Salas-Oropeza, J.; Lopez, H.R.; Jimenez-Estrada, M.; Rosas-Lopez, R.; Duran, D.A.; Flores, C.; Hernandez, L.B.; Rodriguez-Monroy, M.A. Antimicrobial activity of Bursera morelensis ramirez essential oil. Afr. J. Tradit. Complement. Altern. Med. 2017, 14, 74–82. [Google Scholar]
  93. De Christo Scherer, M.M.; Marques, F.M.; Figueira, M.M.; Peisino, M.C.O.; Schmitt, E.F.P.; Kondratyuk, T.P.; Endringer, D.C.; Scherer, R.; Fronza, M. Wound healing activity of terpinolene and α-phellandrene by attenuating inflammation and oxidative stress in vitro. J. Tissue Viability 2019, 28, 94–99. [Google Scholar] [CrossRef]
  94. Winnacker, M. Pinenes: Abundant and renewable building blocks for a variety of sustainable polymers. Angew. Chem. Int. Ed. 2018, 57, 14362–14371. [Google Scholar] [CrossRef]
  95. Salehi, B.; Upadhyay, S.; Orhan, I.E.; Jugran, A.K.; Jayaweera, S.L.D.; Dias, D.A.; Sharopov, F.; Taheri, Y.; Martins, N.; Baghalpour, N.; et al. Therapeutic potential of α- and β-pinene: A miracle gift of nature. Biomolecules 2019, 9, 738. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Juca, D.M.; da Silva, M.T.B.; Palheta Junior, R.C.; de Lima, F.J.; Okoba, W.; Lahlou, S.; de Oliveira, R.B.; dos Santos, A.A.; Magalhaes, P.J.C. The essential oil of Eucalyptus tereticornis and its constituents α- and β-pinene, show accelerative properties on rat gastrointestinal transit. Planta Med. 2011, 77, 57–59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Zhang, Z.; Guo, S.; Liu, X.; Gao, X. Synergistic antitumor effect of alpha-pinene and beta-pinene with paclitaxel against non-small-cell lung carcinoma (NSCLC). Drug Res. 2015, 65, 214–218. [Google Scholar]
  98. Astani, A.; Reichling, J.; Schnitzler, P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother. Res. 2010, 24, 673–679. [Google Scholar] [CrossRef]
  99. Kovac, J.; Simunovic, K.; Wu, Z.; Klancnik, A.; Bucar, F.; Zhang, Q.; Mozina, S.S. Antibiotic resistance modulation and modes of action of (-)-α-pinene in Campylobacter jejuni. PLoS ONE 2015, 10, e0122871. [Google Scholar] [CrossRef] [Green Version]
  100. Matsuo, A.L.; Figueiredo, C.R.; Arruda, D.C.; Pereira, F.V.; Scutti, J.A.B.; Masaoka, M.H.; Travassos, L.R.; Sartorelli, P.; Lago, J.H. α-Pinene isolated from Schinus terebinthifolius Raddi (Anacardiacease) induces apoptosis and confers antimetastatic protection in a melanoma model. Biochem. Biophys. Res. Commun. 2011, 411, 449–454. [Google Scholar] [CrossRef] [Green Version]
  101. Yang, H.; Woo, J.; Pae, A.N.; Um, M.Y.; Cho, N.C.; Park, K.D.; Yoon, M.; Kim, J.; Lee, C.J.; Cho, S. alpha-Pinene, a major constituent of pine tree oils, enhances non-rapid eye movement sleep in mice through GAGAA-benzodiazepine receptors. Mol. Pharmacol. 2016, 90, 530–539. [Google Scholar] [CrossRef] [Green Version]
  102. Nam, S.-Y.; Chung, C.-k.; Seo, J.-H.; Rah, S.-Y.; Kim, H.-M.; Jeong, H.-J. The therapeutic efficacy of α-pinene in an experimental mouse model of allergic rhinitis. Int. Immunopharmacol. 2014, 23, 273–282. [Google Scholar] [CrossRef]
  103. Mahajan, P.; Singh, H.P.; Kaur, S.; Batish, D.R.; Kohli, R.K. β-Pinene moderates Cr(VI) phytotoxicity by quenching reactive oxygen species and altering antioxidant machinery in maize. Environ. Sci. Pollut. Res. 2019, 26, 456–463. [Google Scholar] [CrossRef] [PubMed]
  104. de Macedo Andrade, A.C.; Rosalen, P.L.; Freires, I.A.; Scotti, L.; Scotti, M.T.; Aquino, S.G.; de Castro, R.D. Antifungal activity, mode of action, docking prediction and anti-biofilm effects of (+)-β-piene enantiomers against Cadida spp. Curr. Trend. Med. Chem. 2018, 18, 10. [Google Scholar]
  105. Moreira, I.J.A.; Menezes, P.P.; Serafini, M.R.; Araujo, A.A.S.; Quintans-Junior, L.J.; Bonjardim, L.R.; Filho, V.J.S.; Junior, D.B.P.; Santos, S.L.; Junior, W.L.; et al. Characterization and antihypertensive effect of the complex of (-)-β-pinene in β-cyclodextrin. Curr. Pharm. Biotechnol. 2016, 17, 837–845. [Google Scholar] [CrossRef] [PubMed]
  106. Astani, A.; Schnitzler, P. Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro. Iran. J. Microbiol. 2014, 6, 149–155. [Google Scholar]
  107. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/7462 (accessed on 29 July 2021).
  108. Morais, L.P.D.; Silva, A.A.; Silva, R.E.R.D.; Navarro, D.M.A.F.; Coutinho, H.D.M.; Menezes, I.R.A.D.; Kerntopf, M.R.; Cunha, F.A.B.D.; Leal-Cardoso, J.H.; Barbosa, R. Myorelaxant action of the Cysphania ambrosioides (L.) mosyakin & clemants essential oil and its major constituent α-terpinene in isolated rat trachea. Food Chem. 2020, 325, 126923. [Google Scholar]
  109. de Morais Oliveira-Tintino, C.D.; Tintino, S.R.; Limaverde, P.W.; Figueredo, F.G.; Campina, F.F.; da Cunha, F.A.B.; da Costa, R.H.S.; Pereira, P.S.; Lima, L.F.; de Matos, Y.M.L.S.; et al. Inhibition of the essential oil from Chenophodium ambrosioides L. and α-terpinene on the NorA efflux-pump of Staphylococcus aureus. Food Chem. 2018, 262, 72–77. [Google Scholar]
  110. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/11463 (accessed on 29 July 2021).
  111. Scherf, J.R.; dos Santos, C.R.B.; de Freitas, T.S.; Rocha, J.E.; Macedo, N.S.; Lima, J.N.M.; Coutinho, H.D.M.; da Cunha, F.A.B. Effect of terpinolene against the resistant Staphylococcus aureus stain, carrier of the efflux pump QacC and β-lactamase gene, and its toxicity in the Drosophila melanogaster model. Microb. Pathog. 2020, 149, 104528. [Google Scholar] [CrossRef] [PubMed]
  112. Ito, K.; Ito, M. The sedative effect of inhaled terpinolene in mice and its structure-activity relationship. J. Nat. Med. 2013, 67, 833–837. [Google Scholar] [CrossRef] [PubMed]
  113. Saha, J.; Sengupta, A.; Gupta, K.; Gupta, B. Molecular phylogenetic study and expression analysis of ATP-binding cassette transporter gene family in Oryza sativa in response to salt stress. Comput. Biol. Chem. 2015, 54, 18–32. [Google Scholar] [CrossRef] [PubMed]
  114. Blanco-Rayon, E.; Guilhermino, L.; Irazola, M.; Ivanina, A.V.; Sokolova, I.M.; Izagirre, U.; Marigomez, I. The influence of short-term experimental fasting on biomarker responsiveness in oil WAF exposed mussels. Aquat. Toxicol. 2019, 206, 164–175. [Google Scholar] [CrossRef]
  115. Zhao, P.; Wang, Y.; Huang, W.; He, L.; Lin, Z.; Zhou, J.; He, Q. Toxic effects of terpinolene on Microcystis qeruginosa: Physiological, metabolism, gene transcription, and growth effect. Sci. Total. Environ. 2020, 719, 137376. [Google Scholar] [CrossRef] [PubMed]
  116. Siegel, E.; Wason, S. Camphor toxicity. Pediatr. Clon. North. Am. 1986, 33, 375–379. [Google Scholar] [CrossRef]
  117. Lam, H.R.; Ladefoged, O.; Ostergaard, G.; Lund, S.P.; Simonsen, L. Four weeks’ inhalation exposure of rats to p-cymene affects regional and synaptosomal neurochemistry. Pharmacol. Toxicol. 1996, 79, 225–230. [Google Scholar] [CrossRef]
  118. Mog, S.R.; Zang, Y.J. Safety assessment of food additives: Case example with myrcene, a synthetic flavoring agent. Toxicol. Pathol. 2019, 47, 1035–1037. [Google Scholar] [CrossRef]
  119. Johard, U.; Larsson, K.; Lof, A.; Eklund, A. Controlled short-time terpene exposure induces an increase of the macrophages and the mast cells in bronchoalveolar lavage fluid. Am. J. Ind. Med. 1993, 23, 793–799. [Google Scholar] [CrossRef] [PubMed]
  120. Pubchem Home Page. Available online: http://pubchem.ncbi.nlm.nih.gov/compound/14896 (accessed on 29 July 2021).
  121. Araujo, I.B.; Souza, C.A.M.; De-Carbalho, R.R.; Kuriyama, S.N.; Rodrigues, R.P.; Vollmer, R.S.; Alves, E.N.; Paumgartten, F.J.R. Study of the embryofoetotoxicity of α-terpinene in the rat. Food Chem. Toxicol. 1996, 34, 477–482. [Google Scholar] [CrossRef]
  122. Hall, D.E.; Robert, J.A.; Keeling, C.I.; Domanski, D.; Quesada, A.L.; Jancsik, S.; Kuzyk, M.A.; Hamberger, B.; Borchers, C.H.; Bohlmann, J. An integrated genomic, proteomic and biochemical analysis of (+)-3-carene biosynthesis in Sitka spruce (Picea sitchensis) genotypes that are resistant or susceptible to white pine weevil. Plant. 2011, 65, 936–948. [Google Scholar] [CrossRef]
  123. Boruga, O.; Jianu, C.; Misca, C.; Golet, I.; Gruia, A.T.; Horhat, F.G. Thymus vulgaris essential oil: Chemical composition and antimicrobial activity. J. Med. Life. 2014, 7, 56–60. [Google Scholar] [PubMed]
  124. Ibrahim, E.A.; Wang, M.; Radwan, M.M.; Wanas, A.S.; Majumdar, C.G.; Avula, B.; Wang, W.-H.; Khan, I.; Chandra, S.; Lata, H.; et al. Analysis of terpenes in Cannabis sativa L. using GC/MS: Method development, validation, and application. Planta Med. 2019, 85, 431–438. [Google Scholar] [CrossRef] [PubMed]
  125. Benali, T.; Habbadi, K.; Khabbach, A.; Marmouzi, I.; Zengin, G.; Bouyahya, A.; Chamkhi, I.; Chtibi, H.; Aanniz, T.; Achbbani, E.H.; et al. GC-MS analysis, antioxidant and antimicrobial activities of Achillea odorata subsp. Pectinata and Ruta montana essential oils and their potential use as food preservatives. Foods. 2020, 9, 668. [Google Scholar]
  126. Rabinovich, D. The father of toxicology? Chem. Int. 2009, 30, 3. [Google Scholar]
  127. Bostrom, J.; Brown, D.G.; Young, R.J.; Keseru, G.M. Expanding the medicinal chemistry synthetic toolbox. Nat. Rev. Drug Discov. 2018, 17, 709–727. [Google Scholar] [CrossRef]
  128. NTP TR-557: National Toxicology Program Technical Report-557. Toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123–35–3) in F344/N rats and B6C3F1 mice (gavage studies). Natl. Toxicol. Program. Tech. Rep. Ser. 2010, 557, 1–163. [Google Scholar]
  129. Food Additive Regulations; Synthetic Flavoring Agents and Adjuvants. Available online: https://www.federalregister.gov/documents/2018/10/09/2018-21807/food-additive-regulations-synthetic-flavoring-agents-and-adjuvants (accessed on 26 August 2021).
Ijms 22 09421 g001 550
Figure 1. Mechanisms by which (+)-3-carene enhances sleep by stimulating the GABAA-benzodiazepine receptor (modified from Woo et al. 2019 [20]). ① (+)-3-carene binds on the GABAA-benzodiazepine receptors in the postsynaptic region. ② Cl− flows into the postsynapse. ③ Inhibitory postsynaptic potential (IPSP) occurs, thus enhancing the quality and the duration of sleep under hyperpolarization. Ijms 22 09421 i001: (+)-3-carene; Ijms 22 09421 i002: GABAA-benzodiazepine receptor.
Figure 1. Mechanisms by which (+)-3-carene enhances sleep by stimulating the GABAA-benzodiazepine receptor (modified from Woo et al. 2019 [20]). ① (+)-3-carene binds on the GABAA-benzodiazepine receptors in the postsynaptic region. ② Cl− flows into the postsynapse. ③ Inhibitory postsynaptic potential (IPSP) occurs, thus enhancing the quality and the duration of sleep under hyperpolarization. Ijms 22 09421 i001: (+)-3-carene; Ijms 22 09421 i002: GABAA-benzodiazepine receptor.
Ijms 22 09421 g001
Ijms 22 09421 g002 550
Figure 2. Diagram of apoptosis induction by camphene via mitochondrial dysfunction and endoplasmic reticulum stress (modified from Girola et al. 2015 [22]). Camphene stimulates Ca2+ efflux, downregulates membrane potential to induce mitochondrial dysfunction, induces endoplasmic reticulum stress, increases caspase 3 activation, HmgB2, and calreticulin, and finally results in apoptosis. ↑: increasing; ↓: decreasing.
Figure 2. Diagram of apoptosis induction by camphene via mitochondrial dysfunction and endoplasmic reticulum stress (modified from Girola et al. 2015 [22]). Camphene stimulates Ca2+ efflux, downregulates membrane potential to induce mitochondrial dysfunction, induces endoplasmic reticulum stress, increases caspase 3 activation, HmgB2, and calreticulin, and finally results in apoptosis. ↑: increasing; ↓: decreasing.
Ijms 22 09421 g002
Ijms 22 09421 g003 550
Figure 3. Camphor enhances cold and heat sensation via TRPM8 and TRPV3 and then induces vasoconstriction and vasodilatation (modified from Kotaka et al. 2014 [58]; Selescu et al. 2013 [59]; Steinhoff et al. 2009 [60]). When camphor is applied onto the skin, ① the stimulus affluxes via the dorsal root ganglion and nucleus tractus solitaries and ② up to the somatosensory cortex. Once the response to the stimulus is defined in the brain ③ vasoconstriction occurs if the stimulus was associated to cold temperature, otherwise ④ the blood vessels dilate if a hot temperature is sensed. DRG, dorsal root ganglion; NTS, nucleus tractus solitaries; TRPM8, transient receptor potential melastatin 8; TRPV3, transient receptor potential vanilloid 3. The blue line indicates the conduction of the nervous stimuli.
Figure 3. Camphor enhances cold and heat sensation via TRPM8 and TRPV3 and then induces vasoconstriction and vasodilatation (modified from Kotaka et al. 2014 [58]; Selescu et al. 2013 [59]; Steinhoff et al. 2009 [60]). When camphor is applied onto the skin, ① the stimulus affluxes via the dorsal root ganglion and nucleus tractus solitaries and ② up to the somatosensory cortex. Once the response to the stimulus is defined in the brain ③ vasoconstriction occurs if the stimulus was associated to cold temperature, otherwise ④ the blood vessels dilate if a hot temperature is sensed. DRG, dorsal root ganglion; NTS, nucleus tractus solitaries; TRPM8, transient receptor potential melastatin 8; TRPV3, transient receptor potential vanilloid 3. The blue line indicates the conduction of the nervous stimuli.
Ijms 22 09421 g003
Ijms 22 09421 g004 550
Figure 4. 1,8-cineol downregulates LPS-induced inflammation by blocking both NF-κB translocation and JNK pathway activation (Modified from Greiner et al. 2013 [68]). 1,8-cineol prevents the separation of IκB and NF-κBp65/p55 and then blocks NF-κB translocation from the cytoplasm to the nucleus, thus acting as a transcription factor for the expression of inflammation-related cytokines such as TNF-α and IL-8. Ijms 22 09421 i003: to inhibit the follow action.
Figure 4. 1,8-cineol downregulates LPS-induced inflammation by blocking both NF-κB translocation and JNK pathway activation (Modified from Greiner et al. 2013 [68]). 1,8-cineol prevents the separation of IκB and NF-κBp65/p55 and then blocks NF-κB translocation from the cytoplasm to the nucleus, thus acting as a transcription factor for the expression of inflammation-related cytokines such as TNF-α and IL-8. Ijms 22 09421 i003: to inhibit the follow action.
Ijms 22 09421 g004
Ijms 22 09421 g005 550
Figure 5. Mode of action of p-cymene for the reduction in cancer-associated pain via Ca2+ channel current downregulation, modulation of Fos expression in the spinal cord and pons, and attenuation of mechanical hyperalgesia and nociception in the somatosensory cortex (modified from Santos et al. 2019 [75]). When p-cymene is subcutaneously administered, ① there is a decrease in Ca2+ channel currents and ② the level of Fos expression decreases in the spinal cord. However, ③ Fos expression in the pons, particularly in the nucleus raphe magnus (NRM) and in the periaqueductal gray (PAG), decreases, thus resulting in ④ a decrease in both mechanical hyperalgesia and nociception through the somatosensory cortex, thus attenuating cancer-associated pain. ↑: increasing; ↓: decreasing.
Figure 5. Mode of action of p-cymene for the reduction in cancer-associated pain via Ca2+ channel current downregulation, modulation of Fos expression in the spinal cord and pons, and attenuation of mechanical hyperalgesia and nociception in the somatosensory cortex (modified from Santos et al. 2019 [75]). When p-cymene is subcutaneously administered, ① there is a decrease in Ca2+ channel currents and ② the level of Fos expression decreases in the spinal cord. However, ③ Fos expression in the pons, particularly in the nucleus raphe magnus (NRM) and in the periaqueductal gray (PAG), decreases, thus resulting in ④ a decrease in both mechanical hyperalgesia and nociception through the somatosensory cortex, thus attenuating cancer-associated pain. ↑: increasing; ↓: decreasing.
Ijms 22 09421 g005
Ijms 22 09421 g006 550
Figure 6. Anti-proliferation mechanism of limonene against cancer cells (modified from Shojaei et al. 2014 [80]). Limonene not only induces apoptosis by modulating the bcl-2 gene family and up-regulating pro-apoptotic proteins such as BAD and down-regulating anti-apoptotic proteins such as BCL2, but also by G1 arrest through SMAD regulation and by inhibiting metastasis through suppression of Myc caused by the vascular endothelial growth factor (VEGF) receptor/Akt pathway. Ijms 22 09421 i003: to inhibit the follow action.
Figure 6. Anti-proliferation mechanism of limonene against cancer cells (modified from Shojaei et al. 2014 [80]). Limonene not only induces apoptosis by modulating the bcl-2 gene family and up-regulating pro-apoptotic proteins such as BAD and down-regulating anti-apoptotic proteins such as BCL2, but also by G1 arrest through SMAD regulation and by inhibiting metastasis through suppression of Myc caused by the vascular endothelial growth factor (VEGF) receptor/Akt pathway. Ijms 22 09421 i003: to inhibit the follow action.
Ijms 22 09421 g006
Ijms 22 09421 g007 550
Figure 7. Linalool decreases oxidative stress-induced cell death by regulating glutamate metabolism in the hippocampus (modified from Sabogal-Guaqueta et al. 2019 [27]). In several neurological conditions such as Alzheimer’s disease and neuroinflammation, glutamate induces cysteine influx into the cytoplasm and stimulates oxidative stress, thus inducing apoptosis. Linalool prevents ROS generation and Ca2+ activation in the mitochondria in the cornu ammonis 1 and 3 and dentate gyrus in the hippocampal regions of the brain.
Figure 7. Linalool decreases oxidative stress-induced cell death by regulating glutamate metabolism in the hippocampus (modified from Sabogal-Guaqueta et al. 2019 [27]). In several neurological conditions such as Alzheimer’s disease and neuroinflammation, glutamate induces cysteine influx into the cytoplasm and stimulates oxidative stress, thus inducing apoptosis. Linalool prevents ROS generation and Ca2+ activation in the mitochondria in the cornu ammonis 1 and 3 and dentate gyrus in the hippocampal regions of the brain.
Ijms 22 09421 g007
Ijms 22 09421 g008 550
Figure 8. Myrcene effectively controls UVB-radiated skin aging through MMPs and IL-6 downregulation and collagen synthesis through TGF-β upregulation (Modified from Hwang 2017 [80]). Myrcene not only blocks collagen degradation by protecting UVB-induced ROS but also stimulates collagen synthesis through TGF-β1 activation. UVB-induced ROS finally induces collagen degradation, which is caused by MMP-1, MMP-3, and MMP-9 that are made by transcription factors such as AP-1, cFos, and cJun. UVB radiation inhibits TGF-β1 activation, which stimulates collagen synthesis. Ijms 22 09421 i003: to inhibit the follow action.
Figure 8. Myrcene effectively controls UVB-radiated skin aging through MMPs and IL-6 downregulation and collagen synthesis through TGF-β upregulation (Modified from Hwang 2017 [80]). Myrcene not only blocks collagen degradation by protecting UVB-induced ROS but also stimulates collagen synthesis through TGF-β1 activation. UVB-induced ROS finally induces collagen degradation, which is caused by MMP-1, MMP-3, and MMP-9 that are made by transcription factors such as AP-1, cFos, and cJun. UVB radiation inhibits TGF-β1 activation, which stimulates collagen synthesis. Ijms 22 09421 i003: to inhibit the follow action.
Ijms 22 09421 g008
Ijms 22 09421 g009 550
Figure 9. α-phellandrene promotes wound healing by inhibiting oxidative stress and inflammation, in addition to stimulating wound healing via potent fibroblast activation (modified from de Christo Scherer et al. 2019 [93]). ↑: increasing; Ijms 22 09421 i003: to inhibit the follow action.
Figure 9. α-phellandrene promotes wound healing by inhibiting oxidative stress and inflammation, in addition to stimulating wound healing via potent fibroblast activation (modified from de Christo Scherer et al. 2019 [93]). ↑: increasing; Ijms 22 09421 i003: to inhibit the follow action.
Ijms 22 09421 g009
Ijms 22 09421 g010 550
Figure 10. α- and β-pinene have synergistic anticancer effects against non-small cell lung carcinoma (NSCLC) when co-administered with paclitaxel (Modified from Zhang et al. 2019 [79]). ↑: increasing; ↓: decreasing.
Figure 10. α- and β-pinene have synergistic anticancer effects against non-small cell lung carcinoma (NSCLC) when co-administered with paclitaxel (Modified from Zhang et al. 2019 [79]). ↑: increasing; ↓: decreasing.
Ijms 22 09421 g010
Ijms 22 09421 g011 550
Figure 11. α-terpinen blocks the antibiotic-resistance of Staphylococcus aureus through NorA efflux pump inactivation (modified from de Morais Oliveira-Tintino et al. 2018 [109]).
Figure 11. α-terpinen blocks the antibiotic-resistance of Staphylococcus aureus through NorA efflux pump inactivation (modified from de Morais Oliveira-Tintino et al. 2018 [109]).
Ijms 22 09421 g011
Ijms 22 09421 g012 550
Figure 12. Terpinolene blocks the propagation of Microcystis aeruginosa through ① ROS and MDA-induced photosynthetic inactivity, ② inhibiting the activity of nitrate reductase and glutamine synthetase, and ③ increasing the efficacies of ABC transporters and COX II in the plasma membrane (modified from Zhao et al. 2020 [115]). Reactive oxygen species, ROS; malondialdehyde, MDA; nitrate reductase, NR; glutamine synthetase, GS; ATP-binding cassette transporters, ABC transporter; cytochrome c oxidase subunit II, COX II. ↑: increasing; ↓: decreasing
Figure 12. Terpinolene blocks the propagation of Microcystis aeruginosa through ① ROS and MDA-induced photosynthetic inactivity, ② inhibiting the activity of nitrate reductase and glutamine synthetase, and ③ increasing the efficacies of ABC transporters and COX II in the plasma membrane (modified from Zhao et al. 2020 [115]). Reactive oxygen species, ROS; malondialdehyde, MDA; nitrate reductase, NR; glutamine synthetase, GS; ATP-binding cassette transporters, ABC transporter; cytochrome c oxidase subunit II, COX II. ↑: increasing; ↓: decreasing
Ijms 22 09421 g012
Table
Table 1. Toxicological effects of natural volatile organic compounds (NVOCs).
Table 1. Toxicological effects of natural volatile organic compounds (NVOCs).
Natural Volatile Organic CompoundChemical StructureMolecular Weight (g/mol)Toxicological EffectReferences
(+)-3-carene Ijms 22 09421 i004136.24To irritate pulmonary system and central nervous system[33]
Camphene Ijms 22 09421 i005136.23To irritate serious eye[45]
Camphor Ijms 22 09421 i006152.23To irritate gastrointestinal tract and central nervous system[116]
1,8-cineol Ijms 22 09421 i007154.25Genotoxicity via inducing oxidative DNA damage[35]
p-cymene Ijms 22 09421 i008134.22To induce neurochemical problem by 4 weeks of inhalation[117]
Limonene Ijms 22 09421 i009136.23Hepatotoxicity and neurotoxicity
Oxidized form makes skin allergy.		[36,37]
Linalool Ijms 22 09421 i010154.25To induce skin allergy by oxidized linalool[37]
Myrcene Ijms 22 09421 i011136.23It does not have unique toxicity but in 2018 US FDA decided to stop the usage of it as a food additive.[118]
ɑ-phellandrene Ijms 22 09421 i012136.20To make contact allergy[38]
ɑ-pinene Ijms 22 09421 i013136.23To induce pulmonary inflammation[119]
ß-pinene Ijms 22 09421 i014136.23To irritate skin and mucous system[120]
ɑ-terpinene Ijms 22 09421 i015136.23Embryofoetal toxicity[119]
Terpinolene Ijms 22 09421 i016136.23Oxidized forms can make allergic contact dermatitis.[38]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kim, M.-H.; Lee, S.-M.; An, K.-W.; Lee, M.-J.; Park, D.-H. Usage of Natural Volatile Organic Compounds as Biological Modulators of Disease. Int. J. Mol. Sci. 2021, 22, 9421. https://doi.org/10.3390/ijms22179421

AMA Style

Kim M-H, Lee S-M, An K-W, Lee M-J, Park D-H. Usage of Natural Volatile Organic Compounds as Biological Modulators of Disease. International Journal of Molecular Sciences. 2021; 22(17):9421. https://doi.org/10.3390/ijms22179421

Chicago/Turabian Style

Kim, Min-Hee, Seung-Min Lee, Ki-Wan An, Min-Jae Lee, and Dae-Hun Park. 2021. "Usage of Natural Volatile Organic Compounds as Biological Modulators of Disease" International Journal of Molecular Sciences 22, no. 17: 9421. https://doi.org/10.3390/ijms22179421

APA Style

Kim, M. -H., Lee, S. -M., An, K. -W., Lee, M. -J., & Park, D. -H. (2021). Usage of Natural Volatile Organic Compounds as Biological Modulators of Disease. International Journal of Molecular Sciences, 22(17), 9421. https://doi.org/10.3390/ijms22179421

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop